| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |